Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01038843 · ClinicalTrials.gov registry record · Phase 2
Efficacy Study of VA106483 in Males With Nocturia.
A Phase 2 study, sponsored by Vantia.
- Completed
- Registry status
- Phase 2
- Development phase
- 152
- Enrollment target
NCT01038843 is a Phase 2 study that has completed, run by Vantia. The registered enrollment target is 152 participants.
The verdict
NCT01038843, a Phase 2 study, has completed, sponsored by Vantia.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 152 participants
- Enrollment target
Study Summary
To investigate the effect of VA106483 on nocturia related clinical outcomes compared to placebo.
Interventions
- DRUG VA106483
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2009-12 |
| Est. Completion | 2010-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01038843
The ClinicalTrials.gov registry entry for NCT01038843 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vantia, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which VA106483 is the first listed.
NCT01038843 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01038843 about?
NCT01038843 is a clinical study titled "Efficacy Study of VA106483 in Males With Nocturia.". To investigate the effect of VA106483 on nocturia related clinical outcomes compared to placebo.
What is the current status of trial NCT01038843?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 152 participants. The study started on 2009-12. Estimated completion is 2010-08.
What interventions are being tested in trial NCT01038843?
The interventions under investigation include: VA106483 (DRUG).
Who is sponsoring clinical trial NCT01038843?
This trial is sponsored by Vantia, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.